Indian Billionaires Accelerate Overseas Acquisitions as Domestic Growth Moderates Love Factually Dating Startups Deploy Novel Approaches to Combat Fake Profiles Bond Bull Market May Take a Breather but Remains Intact Expert Suggests AI Demand Possibly Stressing Supplies of Lasers Fiber and Optical Components SNC Scandic Coin Debuts as Regulated RealWorld Asset Project on Major Exchanges Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond Penumbra Q1 2026 Earnings EPS Misses Estimates by 245 Amidst Operational Headwinds OVV Q1 2026 Earnings Strong EPS Beat as Operational Efficiency Drives Surprise PENG Q1 2026 Earnings Strong EPS Beat Drives 9 Surge SLMBP Q1 2026 Earnings Strong EPS Surprise Drives Investor Attention BEEM Q1 2026 Earnings EPS Misses Estimates as Beam Global Reports WiderThanExpected Loss GRBK Q1 2026 Earnings EPS Surges 15 Above Estimates Phillips Edison Company PECO Holds Steady Near Support as Retail REIT Navigates Market Headwinds IHS Holding Limited IHS Holds Steady Near Support as Telecom Infrastructure Stock Consolidates Kymera Therapeutics KYMR Holds Steady at 8136 as Investors Weigh Support and Resistance Levels Allogene Therapeutics Edges Higher Testing Key Resistance at 21 Launchpad Cadenza Acquisition Corp I LPCVU Surges 48 Approaching Key Resistance at 1107 SpiderNoir Receives Mostly Positive Critical Reception on Rotten Tomatoes Market Implications KG Q3 2024 Earnings Loss Reported Amid Limited Disclosure Stock Declines SPS Commerce SPSC Holds Steady Near Midpoint of Key Trading Range MCS Q1 2026 Earnings NarrowerThanExpected Loss Lifts Investor Sentiment Aurora Innovation Q1 2026 Earnings EPS Beat Masks PreRevenue Reality Amid Ongoing Development Costs Pixelworks Q1 2026 Earnings Stunning EPS Beat Overshadowed by Revenue Ambiguity CCS Q1 2026 Earnings EPS Surges Past Expectations Delivering 68 Beat ABCB Q1 2026 Earnings EPS Beats Estimates Stock Slides Slightly WHWK Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline